StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
AD8.AX$2.19+2.82%
Fair $2.19+0.0%

AD8.AX

Audinate Group Limited

Technology / Electronic ComponentsASX

$2.19

+0.06 (+2.82%)

Fairly Valued+0.0%Fair Value $2.19Fund rank 28/100 · Data gapFallback financials|
SA 47/C
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-2.9M · quality 51.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

47/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · AD8.AXLocal privado en este navegador · Audinate Group Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$185M

P/E

17.5x

↓

EV/EBITDA

5.6x

↓

ROE

6.0%

↑

Gross Margin

74.3%

↑

Debt/Equity

0.02

↓
52-Week Range$2
$2$8

TradingView lightweight chart

AD8.AX price, volumen y niveles de valoración

Último $2.190Periodo +43.1%
Fair value: $2.190

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

+40.0%

FCF CAGR

—

FCF margin

11.5%

FCF / Net income

1.02x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $91.5M · net income $10.2M · FCF $10.5M

2021-FY → 2024-FY

Gross margin

74.3%-2.1% pts

Operating margin

9.0%+19.5% pts

Net margin

11.2%+21.5% pts

FCF margin

11.5%+15.3% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$91.5M$91.5M$69.7M$46.3M$33.4M
Net Income$10.2M$10.2M$10.6M$-4.5M$-3.4M
EBITDA$24.3M$24.3M$12.1M$4.4M$3.5M
EPS0.120.120.14-0.06-0.05
Gross Margin74.3%74.3%72.1%74.7%76.4%
Operating Margin9.0%9.0%0.6%-9.4%-10.4%
Net Margin11.2%11.2%15.3%-9.6%-10.3%
Balance Sheet
Debt/Equity0.020.020.030.030.03
Current Ratio6.806.80———
Cash Flow
Free Cash Flow$10.5M$10.5M$-2.9M$-11.1M$-1.3M
Returns
ROE6.0%6.0%11.8%-5.9%-4.4%
Valuation
P/E17.5317.5364.97——
EV/EBITDA5.575.5755.28137.48164.12
P/B1.051.057.678.187.65
Growth & Yield
Revenue Growth31.3%31.3%50.6%38.7%—
EPS Growth-8.1%-8.1%334.3%-27.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

15.9%

exigente

EPS terminal req.

$0.19

Spread vs growth

-24.0%

5Y implied EPS CAGR

13.5%

razonable

EPS terminal req.

$0.24

Spread vs growth

-21.6%

10Y implied EPS CAGR

11.7%

razonable

EPS terminal req.

$0.38

Spread vs growth

-19.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -70.0%

Total return

-70.0%

Start / end P/E

53.8x → 17.5x

EPS bridge

0.14 → 0.12

Residual

+5.5%

EPS growth-8.1%
Multiple rerating-67.4%
Dividend+0.0%
Residual / FX / buybacks / cross-term+5.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.